9 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... hypoglycaemic agents ... #Diabetes #Diabetic ... #Medications #Pharmacology ... Impairment #CKD #Table
Summary of Non-Insulin Agents Used to Treat Diabetes

#Diabetes #Pharmacology #Comparison #Table #Medications #Noninsulin #Orals #Agents
Summary of Non-Insulin ... Agents Used to ... #Diabetes #Pharmacology ... #Comparison #Table ... #Medications #Noninsulin
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
: Agent, Initiation ... Dose and Max Dosages ... Management #Pain #Pharmacology ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Non-Opioid Analgesics - Agents ... #Pain #Pharmacology ... NonOpioid #Analgesics #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Muscle Relaxants - Agents ... #Pain #Pharmacology ... Relaxers #Relaxants #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Distribution, Agents ... and Dosing Table ... Management #Pain #Pharmacology ... Nerve #Blocks #Medications ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
and Nebulized Medications ... - Agents and Dosing ... Management #Pain #Pharmacology ... #Doses #Dosing ... #Table #PAMI
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
Potassium-Binding Agents ... and sodium • Dosing ... #Hyperkalemia #medications ... #pharmacology # ... table #comparison
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... semaglutide, the same medication ... drug to remain stable ... #semaglutide #Diabetes ... #Pharmacology #